Logo
x

Search

Subscribe Now

rare diseases

Selecta Collaborates with Ginkgo to Develop Therapeutic Enzymes for the Treatment of Orphan and Rare Diseases

Selecta Collaborates with Ginkgo to Develop Therapeutic Enzymes for the Treatment of Orphan and Rare Diseases

  • October 27, 2021
Sanofi Collaborates with i2O Therapeutics to Evaluate Oral i2O Therapeutics

Sanofi Collaborates with i2O Therapeutics to Evaluate Oral i2O Therapeutics

  • February 11, 2021
Takeda to Divest its Consumer Health Unit to Blackstone for $2.3B in Japan

Takeda to Divest its Consumer Health Unit to Blackstone for $2.3B in Japan

  • August 24, 2020
Sarepta Signs a Two-Year Research and Option Agreement with Codiak for Up to Five Neuromuscular Targets

Sarepta Signs a Two-Year Research and Option Agreement with Codiak for Up to Five Neuromuscular Targets

  • June 24, 2020
Breaking the Barriers of hATTR Treatment: Thirusha Lane Shares her Insightful Thoughts with PharmaShots

    Breaking the Barriers of hATTR Treatment: Thirusha Lane Shares her Insightful Thoughts with PharmaShots

    • January 22, 2024
    Zevra Therapeutics Resubmits Arimoclomol’s NDA to the US FDA for Treating Niemann-Pick disease Type C (NPC)

      Zevra Therapeutics Resubmits Arimoclomol’s NDA to the US FDA for Treating Niemann-Pick disease Type C (NPC)

      • January 1, 2024
      New Drug Designations - September 2023

        New Drug Designations - September 2023

        • October 16, 2023
        Insights+: EMA Marketing Authorization of New Drugs in May 2023

          Insights+: EMA Marketing Authorization of New Drugs in May 2023

          • June 26, 2023
          Insights+: The US FDA New Drug Approvals in May 2023

            Insights+: The US FDA New Drug Approvals in May 2023

            • June 21, 2023
            Chiesi Global Rare Diseases and Protalix BioTherapeutics Receives the US FDA’s Approval of Elfabrio (pegunigalsidase alfa-iwxj) for Fabry Disease

              Chiesi Global Rare Diseases and Protalix BioTherapeutics Receives the US FDA’s Approval of Elfabrio (pegunigalsidase alfa-iwxj) fo...

              • May 10, 2023
              Image

              Incisive News in 3 Shots.

              Contact Us

              Our Information

              Follow Us

              Copyright © 2025 PharmaShots - All Rights Reserved.